Cardlytics Inc (CDLX)
NASDAQ:CDLX
Want to see CDLX full AI Analyst Report?
CDLX Stock Chart & Stats
$1.01
-$0.18(-5.23%)
At close: 4:00 PM EST
$1.01
-$0.18(-5.23%)
Day’s Range― - ―
52-Week Range$0.57 - $3.28
Previous CloseN/A
Volume316.83K
Average Volume (3M)1.59M
Market Cap
$38.87M
Enterprise Value$213.23M
Total Cash (Recent Filing)$59.80M
Total Debt (Recent Filing)$210.03M
Price to Earnings (P/E)―
Beta2.50
Next Earnings
Aug 04, 2026EPS Estimate
-0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.78
Shares Outstanding57,605,680
10 Day Avg. Volume2,000,092
30 Day Avg. Volume1,587,123
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-9.39
Price to Sales (P/S)0.26
P/FCF Ratio6.93
Enterprise Value/Market Cap5.49
Enterprise Value/Revenue1.04
Enterprise Value/Gross Profit2.21
Enterprise Value/Ebitda-3.12
Forecast
1Y Price Target
$1.00Price Target Upside-0.99% Downside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)-0.88
Revenue Forecast (FY)$152.79M
Bulls Say, Bears Say
Bulls Say
Financial-institution DistributionCardlytics' embedded distribution inside banks' digital channels provides durable access to consumers and proprietary purchase signals. Stabilized FI engagement and upcoming portfolio onboardings support long-term audience scale and data exclusivity that sustain targeting and attribution advantages.
Improving Cash GenerationPositive trailing operating and free cash flow indicate improving self-funding capacity after prior volatility. That cash generation reduces near-term dependence on external financing, supports reinvestment in product and AI, and provides a buffer for executing recovery plans over the next several quarters.
Margin Expansion & Product/AI GainsSustained margin improvement from cost discipline and higher contribution margin implies a structurally leaner operating model. Combined with investments in data and AI that speed reporting and engineering productivity, these gains can sustainably lower unit economics and improve long-term profitability if revenue stabilizes.
Bears Say
Weak Balance Sheet / LeverageElevated leverage and negative shareholders' equity materially constrain financial flexibility. This capital-structure weakness raises refinancing risk, limits ability to absorb continued operating losses, and increases dependency on external liquidity or asset sales to fund strategic investments over the medium term.
Sharp Top-line DeclinesSustained double-digit declines in billings and revenue reflect material erosion of core monetization and advertiser spend. Persistently weaker scale pressures unit economics, reduces bargaining power with partners, and makes margin recoveries harder to sustain without clear, durable revenue re-acceleration.
Loss Of A Major Partner (scale Risk)Losing a very large FI partner is a structural setback to Cardlytics' distribution and data footprint. Reduced MQUs and audience scale lower ad inventory value and attribution accuracy, making it harder to retain/price advertisers and rebuild long-term growth without replacing comparable FI relationships.
Cardlytics News
CDLX FAQ
What was Cardlytics Inc’s price range in the past 12 months?
Cardlytics Inc lowest stock price was $0.57 and its highest was $3.28 in the past 12 months.
What is Cardlytics Inc’s market cap?
Cardlytics Inc’s market cap is $38.87M.
When is Cardlytics Inc’s upcoming earnings report date?
Cardlytics Inc’s upcoming earnings report date is Aug 04, 2026 which is in 64 days.
How were Cardlytics Inc’s earnings last quarter?
Cardlytics Inc released its earnings results on May 07, 2026. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.37 by $0.29.
Is Cardlytics Inc overvalued?
According to Wall Street analysts Cardlytics Inc’s price is currently Overvalued.
Does Cardlytics Inc pay dividends?
Cardlytics Inc does not currently pay dividends.
What is Cardlytics Inc’s EPS estimate?
Cardlytics Inc’s EPS estimate is -0.23.
How many shares outstanding does Cardlytics Inc have?
Cardlytics Inc has 57,605,680 shares outstanding.
What happened to Cardlytics Inc’s price movement after its last earnings report?
Cardlytics Inc reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.37. Following the earnings report the stock price went down -18.054%.
Which hedge fund is a major shareholder of Cardlytics Inc?
Currently, no hedge funds are holding shares in CDLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cardlytics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.00 (-0.99% Downside)
$1.00 (-0.99% Downside)
Blogger Sentiment
Bullish
CDLX Sentiment 100%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 100.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $45.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.00%
12-Months-Change
Fundamentals
Return on Equity
-870.86%
Trailing 12-Months
Asset Growth
-28.49%
Trailing 12-Months
Company Description
Cardlytics Inc
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
CDLX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: strong execution on cost reductions, margin expansion (60.6% adjusted contribution margin), positive adjusted EBITDA on a continued-operations basis, improved cash-flow trends, robust U.K. growth (+21% YoY) and product/AI progress. However, these operational improvements were offset by significant year-over-year declines in core scale metrics (billings -37%, revenue -39%), a 21.3% drop in ACPU, and the material impact of losing Bank of America as a partner. Management provided sequential-growth guidance for Q2, indicating confidence in recovery, but near-term top-line weakness remains notable.View all CDLX earnings summariesCDLX Revenue Breakdown
94.25% U.S.
5.75% U.K.
CDLX Stock 12 Month Forecast
Average Price Target
$1.00
▼(-0.99% Downside)
Technical Analysis
Ownership Overview
12.39% Insiders
6.04% Mutual Funds
27.22% Other Institutional Investors
49.94% Public Companies and
Individual Investors